FDA Introduces SPL Xforms for Effortless Cosmetic Product Facility Registration

Fda Announces The Availability Of Additional Submission Tools For Cosmetic Product Facility Registration And Cosmetic Product Listing
On 8 January 2024, the U.S. Food and Drug Administration (FDA) announced the availability of SPL Xforms, a Structured Product Labeling (SPL) authoring tool for cosmetic product facility registration and cosmetic product listing mandated by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA).
Xforms offers a choice for generating SPL files for cosmetic product registration and listing. FDA accepts electronic submissions through Cosmetic Direct or ESG for cosmetic facility registrations and product listings.
Regulatory Intelligence Support

Have a
regulatory affairs

Regulatory Affair Icon